{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:31:46Z","timestamp":1778970706053,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis investigated whether the use of azithromycin during labour or caesarean section reduces the incidence of sepsis and infection among mothers and newborns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>We independently searched the PubMed, Web of Science, Cochrane Library and EMBASE databases for relevant studies published before February, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included RCTs that evaluated the effect of prenatal oral or intravenous azithromycin or placebo on intrapartum or postpartum infection incidence. We included studies evaluating women who had vaginal births as well as caesarean sections. Studies reporting maternal and neonatal infections were included in the current analysis. Review Manager 5.4 was used to analyse 6 randomized clinical trials involving 44,448 mothers and 44,820 newborns. The risk of bias of each included study was assessed using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions.Primary outcomes included the incidence of maternal sepsis and all-cause mortality and neonatal sepsis and all-cause mortality; secondary outcomes included maternal (endometritis, wound and surgical site infections, chorioamnionitis, and urinary tract infections) and neonatal outcomes (infections of the eyes, ears and skin). A random-effects model was used to test for overall effects and heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The pooled odds ratios (ORs) were as follows: 0.65 for maternal sepsis (95% CI, 0.55\u20130.77;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      , 0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.00001); 0.62 for endometritis (95% CI, 0.52\u20130.74;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      , 2%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.00001); and 0.43 for maternal wound or surgical site infection (95% CI, 0.24\u20130.78;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.005); however, there was great heterogeneity among the studies (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      , 75%). The pooled OR for pyelonephritis and urinary tract infections was 0.3 (95% CI, 0.17\u20130.52;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      , 0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.0001), and that for neonatal skin infections was 0.48 (95% CI, 0.35\u20130.65;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      , 0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.00001). There was no significant difference in maternal all-cause mortality or incidence of chorioamnionitis between the two groups. No significant differences were observed in the incidence of neonatal sepsis or suspected sepsis, all-cause mortality, or infections of the eyes or ears.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this meta-analysis, azithromycin use during labour reduced the incidence of maternal sepsis, endometritis, incisional infections and urinary tract infections but did not reduce the incidence of neonatal-associated infections, except for neonatal skin infections. These findings indicate that azithromycin may be potentially beneficial for maternal postpartum infections, but its effect on neonatal prognosis remains unclear. Azithromycin should be used antenatally only if the clinical indication is clear and the potential benefits outweigh the harms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-024-06390-6","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T06:02:43Z","timestamp":1710396163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Can the use of azithromycin during labour reduce the incidence of infection among puerperae and newborns? A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"24","author":[{"given":"Haiyan","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"issue":"9966","key":"6390_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","volume":"385","author":"L Liu","year":"2015","unstructured":"Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet (London England). 2015;385(9966):430\u201340.","journal-title":"Lancet (London England)"},{"issue":"3","key":"6390_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/QCO.0b013e328339257c","volume":"23","author":"J van Dillen","year":"2010","unstructured":"van Dillen J, Zwart J, Schutte J, et al. Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis. 2010;23(3):249\u201354.","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"6390_CR3","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Global Health"},{"issue":"9730","key":"6390_CR4","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","volume":"375","author":"RE Black","year":"2010","unstructured":"Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (London England). 2010;375(9730):1969\u201387.","journal-title":"Lancet (London England)"},{"key":"6390_CR5","doi-asserted-by":"crossref","unstructured":"Lawn JE, Cousens S, Zupan. J. 4 million neonatal deaths: when? Where? Why?. Lancet (London, England), 2005, 365(9462): 891\u2013900.","DOI":"10.1016\/S0140-6736(05)71048-5"},{"issue":"9705","key":"6390_CR6","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(09)61339-8","volume":"374","author":"CL Cutland","year":"2009","unstructured":"Cutland CL, Madhi SA, Zell ER, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (London England). 2009;374(9705):1909\u201316.","journal-title":"Lancet (London England)"},{"issue":"2","key":"6390_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","volume":"143","author":"MJ Parnham","year":"2014","unstructured":"Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014;143(2):225\u201345.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"6390_CR8","doi-asserted-by":"publisher","first-page":"e20162281","DOI":"10.1542\/peds.2016-2281","volume":"139","author":"C Oluwalana","year":"2017","unstructured":"Oluwalana C, Camara B, Bottomley C, et al. Azithromycin in Labor lowers clinical infections in mothers and newborns: a double-blind trial. Pediatrics. 2017;139(2):e20162281.","journal-title":"Pediatrics"},{"issue":"4","key":"6390_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1067\/mob.2001.111303","volume":"184","author":"D Chelmow","year":"2001","unstructured":"Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gynecol. 2001;184(4):656\u201361.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"6390_CR10","first-page":"Cd007482","volume":"2014","author":"FM Smaill","year":"2014","unstructured":"Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014;2014(10):Cd007482.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6390_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/AOG.0000000000002129","volume":"130","author":"LM Harper","year":"2017","unstructured":"Harper LM, Kilgore M, Szychowski JM, et al. Economic evaluation of adjunctive azithromycin Prophylaxis for Cesarean Delivery. Obstet Gynecol. 2017;130(2):328\u201334.","journal-title":"Obstet Gynecol"},{"key":"6390_CR12","doi-asserted-by":"crossref","unstructured":"Roca A, Oluwalana C, Bojang A et al. Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious diseases, 2016, 22(6): e5651\u20139.","DOI":"10.1016\/j.cmi.2016.03.005"},{"issue":"13","key":"6390_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","volume":"375","author":"AT Tita","year":"2016","unstructured":"Tita AT, Szychowski JM, Boggess K, et al. Adjunctive azithromycin Prophylaxis for Cesarean Delivery. N Engl J Med. 2016;375(13):1231\u201341.","journal-title":"N Engl J Med"},{"issue":"5","key":"6390_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/AOG.0000000000004565","volume":"138","author":"A Subramaniam","year":"2021","unstructured":"Subramaniam A, Ye Y, Mbah R, et al. Single dose of oral azithromycin with or without Amoxicillin to Prevent Peripartum infection in laboring, high-risk women in Cameroon: a Randomized Controlled trial. Obstet Gynecol. 2021;138(5):703\u201313.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"6390_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1517\/17425255.2011.598506","volume":"7","author":"RM Chico","year":"2011","unstructured":"Chico RM, Chandramohan D. Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin Drug Metab Toxicol. 2011;7(9):1153\u201367.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"6390_CR16","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"issue":"10","key":"6390_CR17","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7414","key":"6390_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ (Clinical Res ed). 2003;327(7414):557\u201360.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"9","key":"6390_CR19","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.4103\/jfmpc.jfmpc_593_19","volume":"8","author":"MS Jyothi","year":"2019","unstructured":"Jyothi MS, Kalra JK, Arora A, et al. Randomized controlled trial of cefazolin monotherapy versus cefazolin plus azithromycin single dose prophylaxis for cesarean deliveries: a developing country\u2019s perspective. J Family Med Prim care. 2019;8(9):3015\u201321.","journal-title":"J Family Med Prim care"},{"issue":"9","key":"6390_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.2022.24388","volume":"329","author":"A Roca","year":"2023","unstructured":"Roca A, Camara B, Bognini JD, et al. Effect of Intrapartum Azithromycin vs Placebo on neonatal Sepsis and death: a Randomized Clinical trial. JAMA. 2023;329(9):716\u201324.","journal-title":"JAMA"},{"issue":"13","key":"6390_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMoa2212111","volume":"388","author":"ATN Tita","year":"2023","unstructured":"Tita ATN, Carlo WA, McClure EM, et al. Azithromycin to prevent Sepsis or death in Women planning a vaginal birth. N Engl J Med. 2023;388(13):1161\u201370.","journal-title":"N Engl J Med"},{"key":"6390_CR22","doi-asserted-by":"crossref","unstructured":"Crosara LF, Orsini PVB, Eskandar K et al. Single-dose oral azithromycin prophylaxis in planned vaginal delivery for sepsis prevention: a systematic review and meta-analysis of randomized controlled trials. Int J Gynaecol Obstet, 2023, Advance online publication.","DOI":"10.1002\/ijgo.15124"},{"issue":"3","key":"6390_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1471-0528.17655","volume":"131","author":"I Kuitunen","year":"2024","unstructured":"Kuitunen I, Kekki M, Renko M. Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: a systematic review with meta-analysis. BJOG: Int J Obstet Gynecol. 2024;131(3):246\u201355.","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"6","key":"6390_CR24","first-page":"1183","volume":"101","author":"WW Andrews","year":"2003","unstructured":"Andrews WW, Hauth JC, Cliver SP, et al. Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. Obstet Gynecol. 2003;101(6):1183\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6390_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.AOG.0000295868.43851.39","volume":"111","author":"AT Tita","year":"2008","unstructured":"Tita AT, Hauth JC, Grimes A, et al. Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis. Obstet Gynecol. 2008;111(1):51\u20136.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"6390_CR26","doi-asserted-by":"publisher","first-page":"e3031","DOI":"10.1016\/j.ajog.2008.06.068","volume":"199","author":"AT Tita","year":"2008","unstructured":"Tita AT, Owen J, Stamm AM, et al. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. Am J Obstet Gynecol. 2008;199(3):e3031\u20133.","journal-title":"Am J Obstet Gynecol"},{"key":"6390_CR27","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstetrics and gynecology. 2018, 132(3): e103-e19.","DOI":"10.1097\/AOG.0000000000002833"},{"issue":"6","key":"6390_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ajog.2021.12.262","volume":"226","author":"RD Seaman","year":"2022","unstructured":"Seaman RD, Kopkin RH, Turrentine MA. Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(6):794\u2013e8011.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"6390_CR29","doi-asserted-by":"publisher","first-page":"EVIDoa2100054","DOI":"10.1056\/EVIDoa2100054","volume":"1","author":"CE Oldenburg","year":"2022","unstructured":"Oldenburg CE, Si\u00e9 A, Bountogo M, et al. Neonatal azithromycin administration for prevention of infant mortality. NEJM Evid. 2022;1(4):EVIDoa2100054.","journal-title":"NEJM Evid"},{"issue":"1","key":"6390_CR30","doi-asserted-by":"publisher","first-page":"e00984","DOI":"10.1128\/mSphere.00984-19","volume":"5","author":"P Zhou","year":"2020","unstructured":"Zhou P, Zhou Y, Liu B, et al. Perinatal antibiotic exposure affects the transmission between maternal and neonatal microbiota and is Associated with early-onset Sepsis. mSphere. 2020;5(1):e00984\u201319.","journal-title":"mSphere"},{"issue":"5","key":"6390_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00006454-200205000-00005","volume":"21","author":"TM Shelby-James","year":"2002","unstructured":"Shelby-James TM, Leach AJ, Carapetis JR, et al. Impact of single dose azithromycin on group a streptococci in the upper respiratory tract and skin of Aboriginal children. Pediatr Infect Dis J. 2002;21(5):375\u201380.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"6390_CR32","doi-asserted-by":"publisher","first-page":"e0157045","DOI":"10.1371\/journal.pone.0157045","volume":"11","author":"J Kimani","year":"2016","unstructured":"Kimani J, Phiri K, Kamiza S, et al. Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium Falciparum Malaria infection in pregnant women in Africa: an Open-Label, Randomized Trial. PLoS ONE. 2016;11(6):e0157045.","journal-title":"PLoS ONE"},{"key":"6390_CR33","doi-asserted-by":"crossref","unstructured":"Muanda FT, Sheehy O, B\u00e9rard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ: Canadian Medical Association journal\u2009=\u2009journal de l\u2019Association medicale canadienne, 2017, 189(17): E625\u201333.","DOI":"10.1503\/cmaj.161020"},{"issue":"6","key":"6390_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ajog.2019.06.050","volume":"221","author":"P Damkier","year":"2019","unstructured":"Damkier P, Br\u00f8nniche LMS, Korch-Frandsen JFB, et al. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. Am J Obstet Gynecol. 2019;221(6):648. .e1-.e15.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"6390_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ped.13738","volume":"61","author":"SH Kim","year":"2019","unstructured":"Kim SH, Chun J, Ko KH, et al. Effect of antenatal azithromycin for Ureaplasma spp. on neonatal outcome at \u2264\u200930 weeks\u2019 gestational age. Pediatr Int. 2019;61(1):58\u201362.","journal-title":"Pediatr Int"},{"issue":"1","key":"6390_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00404-020-05569-4","volume":"302","author":"A Omranipoor","year":"2020","unstructured":"Omranipoor A, Kashanian M, Dehghani M, et al. Association of antibiotics therapy during pregnancy with spontaneous miscarriage: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;302(1):5\u201322.","journal-title":"Arch Gynecol Obstet"},{"key":"6390_CR37","doi-asserted-by":"crossref","unstructured":"Leke AZ, Dolk H, Loane M et al. Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: a European case-control study. Reproductive toxicology (Elmsford, NY), 2021, 100:101\u20138.","DOI":"10.1016\/j.reprotox.2021.01.006"},{"issue":"11","key":"6390_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s40261-022-01203-0","volume":"42","author":"R Antonucci","year":"2022","unstructured":"Antonucci R, Cuzzolin L, Locci C, et al. Use of azithromycin in pregnancy: more doubts than certainties. Clin Drug Investig. 2022;42(11):921\u201335.","journal-title":"Clin Drug Investig"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06390-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06390-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T06:05:32Z","timestamp":1710396332000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06390-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6390"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06390-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3779604\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}